Strategy Sold Bitcoin, but It’s Not What You Think Right Now
A small BTC sale by Strategy is not a capitulation. The firm says the move funds preferred stock distributions while ...
Using Past Spending To Inform Future Budget
Leverage past spending insights to shape your future budget and improve financial forecasting for upcoming months.
21,942 articlesSenate Returns with Clarity: CBDC Blocked, Stablecoins Win
The Senate returns with clarity as it places a hard mark against a Federal Reserve retail CBDC, while advancing a fra...
Microsoft Turns OpenClaw Into an Enterprise AI Agent
Microsoft is transforming an open AI framework into a full blown enterprise tool. Scout harnesses OpenClaw to manage ...
Agree Realty Roth IRA: Max Monthly Dividend Income
As markets wobble, investors eye tax-efficient income. This report explains how a Roth IRA can magnify monthly divide...
SpaceX Breaks IPO Playbook with Fixed-Price Offering
SpaceX priced its IPO at a fixed $135 per share, aiming to raise roughly $75 billion and valuing the company around $...
Stock Market Today, June: Nu Buyback Sparks Jump in Shares
Nu Holdings approves a $1 billion share buyback, triggering a stock jump that investors will watch closely. Here’s wh...
Apple Set to Make Its Biggest AI Bet at WWDC This Monday
Apple readies its largest AI push at WWDC, centering on Siri and the iPhone as an AI gateway. The move could reshape ...
Why Archer Aviation Stock Plummeted Today: Key Drivers
When archer aviation stock plummeted, traders searched for the root causes. This guide breaks down the catalysts, inc...
June FOMC June Bitcoin’s Next Move Shaping Markets
Bitcoin sits at a crossroads as CPI data on June 10 and the FOMC dot plot on June 17 collide in a tight seven-day win...
Elon Musk Says ASML Emerges as Europe’s Greatest Company Yet
Elon Musk says ASML has cemented its status as Europe’s top tech company, a claim that reverberates through chip equi...
CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Zcash Rallies Above $470 as Ironwood Upgrade Looms
Zcash climbs above $470 as investors react to news of the Ironwood upgrade slated for late July. The changes aim to m...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status